Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
N
Nykode Therapeutics ASA
SWB:5VB
Nykode Therapeutics ASA
SWB:5VB
Price:
0.2985
EUR
-3.55%
Market Closed
Market Cap:
€97.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nykode Therapeutics ASA
SWB:5VB
|
NO |
|
Errawarra Resources Ltd
ASX:WCE
|
AU |
|
Tokyo Metro Co Ltd
F:XO7
|
JP |
|
New Fortress Energy Inc
NASDAQ:NFE
|
US |
|
Aspen Digital Inc
OTC:ASPD
|
US |
|
F
|
Firan Technology Group Corp
SWB:22F
|
CA |
|
J
|
Jones Soda Co
CNSX:JSDA
|
US |
|
C
|
Chiyoda Corp
F:CYA
|
JP |
|
A
|
Alar Pharmaceuticals Inc
TPEX:6785
|
TW |
|
Signaux Girod SA
PAR:ALGIR
|
FR |
|
G
|
Great Eagle Holdings Ltd
XMUN:GHK
|
BM |
|
E
|
Emerald Resources NL
OTC:EOGSF
|
AU |
|
Y
|
Y Biologics Inc
KOSDAQ:338840
|
KR |
Wall St Price Targets
5VB Price Forecast
Based on 3 analysts
Based on 3 analysts
+87% Upside
from
€0.2985
today
Nykode Therapeutics ASA (5VB)’s 12-month stock price forecast through October 2027 has a consensus target of €0.558, implying 87% upside. The forecast is based on price targets from 3 Wall Street analysts.
Nykode Therapeutics ASA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5VB's stock price target?
Price Target
0.558
EUR
0.558
EUR
According to Wall Street analysts, the average 1-year price target for 5VB is 0.558 EUR with a low forecast of 0.4862 EUR and a high forecast of 0.6434 EUR.